Kathryn Grace , Nathaniel M. Schuster , Clark C. Smith
{"title":"International Pain and Spine Intervention Society Emergency Protocols: Epidural Hematoma","authors":"Kathryn Grace , Nathaniel M. Schuster , Clark C. Smith","doi":"10.1016/j.inpm.2026.100794","DOIUrl":"10.1016/j.inpm.2026.100794","url":null,"abstract":"<div><div>This protocol addresses the diagnosis and emergency management of epidural hematoma, a rare but potentially catastrophic complication of neuraxial procedures. It reviews key risk factors such as anticoagulation, traumatic needle placement, and coagulopathy, as well as warning signs including severe axial pain, neurologic deficits, and bowel or bladder dysfunction. The protocol emphasizes urgent imaging, spine surgical consultation, and rapid intervention to prevent permanent neurologic injury.</div></div>","PeriodicalId":100727,"journal":{"name":"Interventional Pain Medicine","volume":"5 2","pages":"Article 100794"},"PeriodicalIF":0.0,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148184423","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Patrick H. Waring , Fred DeFrancesch , Kathryn Grace
{"title":"International Pain and Spine Intervention Society Emergency Protocols: Oversedation","authors":"Patrick H. Waring , Fred DeFrancesch , Kathryn Grace","doi":"10.1016/j.inpm.2026.100792","DOIUrl":"10.1016/j.inpm.2026.100792","url":null,"abstract":"<div><div>This protocol focuses on the prevention and management of oversedation associated with intravenous conscious sedation during interventional pain procedures. It reviews the pharmacology and risks of commonly used sedative agents, including benzodiazepines, opioids, and propofol. Management priorities include early recognition of respiratory depression, airway support, administration of reversal agents such as naloxone or flumazenil when indicated, continuous monitoring, and adherence to Basic Life Support/Advanced Cardiovascular Life Support protocols.</div></div>","PeriodicalId":100727,"journal":{"name":"Interventional Pain Medicine","volume":"5 2","pages":"Article 100792"},"PeriodicalIF":0.0,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148184425","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"International Pain and Spine Intervention Society Emergency Protocols: Pneumothorax","authors":"Ronald A. Wasserman , Ryan M. Meral , Mihir Joshi","doi":"10.1016/j.inpm.2026.100779","DOIUrl":"10.1016/j.inpm.2026.100779","url":null,"abstract":"<div><div>This protocol describes the recognition and treatment of pneumothorax and tension pneumothorax as potential complications of procedures performed near the pleura. It reviews clinical presentations ranging from mild dyspnea and chest pain to life-threatening respiratory distress and hemodynamic instability. The protocol emphasizes rapid diagnosis, supplemental oxygen administration, emergency decompression for unstable patients, and urgent transfer for definitive management.</div></div>","PeriodicalId":100727,"journal":{"name":"Interventional Pain Medicine","volume":"5 2","pages":"Article 100779"},"PeriodicalIF":0.0,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148184521","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Nathaniel M. Schuster , Stephan Klessinger , Patrick H. Waring
{"title":"International Pain and Spine Intervention Society Emergency Protocols: Intra-arterial Injection","authors":"Nathaniel M. Schuster , Stephan Klessinger , Patrick H. Waring","doi":"10.1016/j.inpm.2026.100776","DOIUrl":"10.1016/j.inpm.2026.100776","url":null,"abstract":"<div><div>This protocol discusses the risks associated with inadvertent intra-arterial injection during spine interventions, including stroke, seizure, spinal cord infarction, and paralysis. It highlights the dangers of particulate steroid embolism and arterial vasospasm, particularly during transforaminal injections. The protocol focuses on immediate recognition, termination of the procedure, activating stroke protocols, neurologic assessment, airway management, and rapid transfer for advanced neurologic care.</div></div>","PeriodicalId":100727,"journal":{"name":"Interventional Pain Medicine","volume":"5 2","pages":"Article 100776"},"PeriodicalIF":0.0,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148231359","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Quantitative discometry: Low-dose concordant pain onset identifies sensitized annular nociceptors under pressure–volume–controlled provocation","authors":"Richard Derby , Yakov Vorobeychik","doi":"10.1016/j.inpm.2026.100738","DOIUrl":"10.1016/j.inpm.2026.100738","url":null,"abstract":"<div><h3>Background</h3><div>Provocative discography is controversial because it couples mechanically induced disc stimulation to a subjective pain report and is often interpreted as a simple yes/no test of “discogenic pain.” Pressure–volume–controlled discography (“discometry”) allows disc provocation to be treated as a dose–response experiment using static pressure above opening (ΔP) and cumulative mechanical work (W), rather than pressure alone.</div></div><div><h3>Objective</h3><div>To determine whether discs that reproduce a patient's concordant pain under pressure–volume control exhibit a distinct low-dose onset phenotype compared with discs that never declare, and to interpret these patterns in the context of annular versus vertebrogenic pain mechanisms.</div></div><div><h3>Methods</h3><div>We retrospectively analyzed pressure–volume–controlled lumbar discography from a single outpatient spine practice. Discs were injected in fixed volume increments with static plateau pressures recorded at each step under protocol caps (ΔP ≤ 50 psi above opening; volume ≤3.5 mL). For each disc, we identified either the onset event (first 0.5 mL step with definite concordant pain ≥4/10, sustained ≥30 s) or a final-negative (censored) event if no onset occurred under the caps (i.e., the disc “never declared”). Static ΔP at the event (ΔP_event) and cumulative mechanical work (W_event = Σ ΔP × ΔV) were calculated, and an energy-equivalent stiffness (K_eq = 2W/V<sup>2</sup>) was derived. We compared onset versus censored doses across MRI morphologies (normal, fissured, disrupted), within encounters containing both positive and negative discs, and across apparatus conditions, and examined the volume step at which onset occurred.</div></div><div><h3>Results</h3><div>Structurally abnormal discs that reproduced the presenting pain almost always did so at relatively low ΔP_event and W_event, yet with moderate-to-severe pain intensity at onset. Discs that never declared under the same protocol caps tolerated substantially higher ΔP_event and W_event, and morphologically normal discs clustered at the extreme of high-dose tolerance with rare positive responses. This separation between low-dose onset and high-dose tolerance persisted within fissured and disrupted strata, within encounters (positive vs negative discs in the same patient), and after stiffness normalization using K_eq, arguing against generalized “softness” as the sole explanation. In a subset with complete step-index data, most onset-positive discs declared by approximately 1.7 mL of injected volume and nearly all by 1.7–2.2 mL under slow, staged injection.</div></div><div><h3>Conclusion</h3><div>These findings support a reproducible low-dose, high-intensity concordant pain phenotype in structurally abnormal discs, most consistent with chemically and mechanically sensitized nociceptors in the annulus and at the annulus–endplate junction. Other discs—whether morphologically normal or with more prominent v","PeriodicalId":100727,"journal":{"name":"Interventional Pain Medicine","volume":"5 1","pages":"Article 100738"},"PeriodicalIF":0.0,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146078514","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Regulatory, ethical, and clinical barriers to exosome use in interventional pain medicine","authors":"Alexandre J. Bourcier , Zbigniew M. Kirkor","doi":"10.1016/j.inpm.2026.100746","DOIUrl":"10.1016/j.inpm.2026.100746","url":null,"abstract":"<div><div>Exosome-based therapies have drawn growing attention in interventional pain medicine as clinicians look for regenerative options beyond corticosteroids, radiofrequency ablation, and cell-based procedures. The early preclinical work suggests anti-inflammatory and neuromodulatory effects relevant to muskuloskeletal and spine pain. However, this promise is currently outpaced by clinical marketing. No exosome product is United States Food and Drug Administration (FDA) approved for musculoskeletal or pain indications, and all therapeutic use in the United States requires an Investigational New Drug application, Institutional Review Board oversight, and Good Manufacturing Practice (GMP) grade manufacturing. Despite this, a parallel cash-pay market has expanded, offering “361-compliant” or “minimally manipulated” exosomes for intradiscal, epidural, or joint injection, in direct conflict with FDA guidelines.</div><div>This review outlines the regulatory landscape governing exosome products in the United States, Europe, and Asia; describes key manufacturing and characterization challenges that undermine consistency and potency; and examines the ethical and medico-legal issues created when unapproved biologics are marketed directly to patients. Scientific barriers remain substantial, including heterogeneous isolation techniques, unstable product profiles, unresolved dosing metrics, and limited human data. These gaps, combined with high economic barriers to GMP production, prevent exosomes from being responsibly incorporated into interventional pain practice.</div></div>","PeriodicalId":100727,"journal":{"name":"Interventional Pain Medicine","volume":"5 1","pages":"Article 100746"},"PeriodicalIF":0.0,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147396956","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Stephan Klessinger , Rezvan Ahmadi , Christopher Büttner , Hans-Raimund Casser , Christian Ewelt , Robert Fessl , Holger Koepp , Heike Norda , Hela-F. Petereit , Philipp Pieroh , Matthias Pumberger , Heike Rittner , Markus Schneider , Christoph Trumm , Hayrettin Tumani , Patrick Weidle , Daniel A. Weiss , Karsten Wiechert
{"title":"Time to standardize: The German Spine Society national clinical guideline on epidural injections","authors":"Stephan Klessinger , Rezvan Ahmadi , Christopher Büttner , Hans-Raimund Casser , Christian Ewelt , Robert Fessl , Holger Koepp , Heike Norda , Hela-F. Petereit , Philipp Pieroh , Matthias Pumberger , Heike Rittner , Markus Schneider , Christoph Trumm , Hayrettin Tumani , Patrick Weidle , Daniel A. Weiss , Karsten Wiechert","doi":"10.1016/j.inpm.2025.100720","DOIUrl":"10.1016/j.inpm.2025.100720","url":null,"abstract":"","PeriodicalId":100727,"journal":{"name":"Interventional Pain Medicine","volume":"5 1","pages":"Article 100720"},"PeriodicalIF":0.0,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145841680","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Sean Pickard , David Speach , Kurt Hauber , Wesley Edwards , Andrea Baran , Alyssa Fedorko
{"title":"Return to work rates of workers compensation patients with lumbar radiculopathy following epidural steroid injection","authors":"Sean Pickard , David Speach , Kurt Hauber , Wesley Edwards , Andrea Baran , Alyssa Fedorko","doi":"10.1016/j.inpm.2026.100736","DOIUrl":"10.1016/j.inpm.2026.100736","url":null,"abstract":"<div><h3>Background</h3><div>Low back injury is one of the leading causes of work-related injuries, disability, and lost productivity. Patients with lumbar radiculopathy are a subgroup of patients within work related low back injury. To our knowledge, there are few studies that specifically assessed the relationship between treating radiculopathy with an epidural injection and return to duty for injured workers. Treatments such as lumbar epidural steroid injection (ESI) that potentially expedite safe return to work could have cost-saving benefits by reducing the need for spine surgery while ameliorating an injured worker's pain and suffering.</div></div><div><h3>Objective</h3><div>The objective of the study is to estimate the return-to-work rate in worker's compensation patients treated at a single academic site who were diagnosed with work related low back injury with lumbar radicular pain and treated with lumbar ESI.</div></div><div><h3>Methods</h3><div>Electronic medical record data was obtained from the University of Rochester Clinical & Translational Science Institute in a retrospective review. Patients evaluated in the departments of Physical Medicine and Rehabilitation or Orthopaedics at a tertiary care medical center from January 1, 2012 to October 31, 2023. with at least one visit for lumbar radiculopathy, lumbar spinal stenosis and lumbar disc herniation were included in the study. Return to work rates were estimated from all workers treated with a lumbar ESI. Patient age, gender and number of injections were evaluated for their effect on RTW rate.</div></div><div><h3>Results</h3><div>23 of 222 patients treated with a lumbar ESI returned to work, this totaled 10.4 % of the subgroup (95 % CI: 6.7 %–15.1 %). There was insufficient evidence of an association between gender and return to work following treatment with a lumbar ESI (OR for male = 1.09, 95 % CI 0.44–2.69, p = 0.86). Similarly, there was no association between the number of injections and return to work. (OR for 3+ injections compared to 1–2 injections 0.73, 95 % CI 0.30–1.80, p = 0.49). However, we observed a decrease in likelihood of returning to work as age increases in patients treated with ESI (OR per 10 years of age = 0.51, 95 % CI 0.36–0.73, p = 0.0002).</div></div><div><h3>Conclusion</h3><div>Return to work rates in worker's compensation patients were 10.4 % after treatment with lumbar ESIs. It appears that even with treatment of lumbar ESIs, worker's compensation patients with lumbar radiculopathy had a low chance of returning to work.</div></div>","PeriodicalId":100727,"journal":{"name":"Interventional Pain Medicine","volume":"5 1","pages":"Article 100736"},"PeriodicalIF":0.0,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146173508","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}